Zhang H, Guan W, Zhou J
Infect Drug Resist. 2025; 18:483-493.
PMID: 39882252
PMC: 11776534.
DOI: 10.2147/IDR.S504632.
Irvine E, Darrah P, Wang S, Wang C, McNamara R, Roederer M
iScience. 2024; 27(12):111128.
PMID: 39669431
PMC: 11634979.
DOI: 10.1016/j.isci.2024.111128.
Achdiat P, Suwarsa O, Hidayat Y, Shafiee M, Dwiyana R, Hindritiani R
Immunotargets Ther. 2024; 13:123-150.
PMID: 38476374
PMC: 10929246.
DOI: 10.2147/ITT.S446938.
Echeverria G, Zumarraga M, Proano-Perez F, Blasco F, de Waard J
Sci Rep. 2024; 14(1):5155.
PMID: 38431678
PMC: 10908831.
DOI: 10.1038/s41598-024-52089-1.
Panda S, Morgan J, Cheng C, Saito M, Gilman R, Ciobanu N
Nat Commun. 2024; 15(1):765.
PMID: 38278794
PMC: 10817963.
DOI: 10.1038/s41467-024-45058-9.
Tuberculin test using Indian indigenous purified-protein derivative (PPD) shows only moderate agreement with international standard PPD.
Christopher D, Priya N, Shankar D, Isaac B, DeLuca A, Sarkar S
J Clin Tuberc Other Mycobact Dis. 2024; 34:100404.
PMID: 38174327
PMC: 10761766.
DOI: 10.1016/j.jctube.2023.100404.
A Comparative Study on the Mechanism of Delayed-Type Hypersensitivity Mediated by the Recombinant Fusion Protein ESAT6-CFP10 and Purified Protein Derivative.
Guo X, Du W, Li J, Dong J, Shen X, Su C
Int J Mol Sci. 2023; 24(23).
PMID: 38068935
PMC: 10706316.
DOI: 10.3390/ijms242316612.
Tackling Drug-Resistant Tuberculosis: New Challenges from the Old Pathogen .
Mancuso G, Midiri A, De Gaetano S, Ponzo E, Biondo C
Microorganisms. 2023; 11(9).
PMID: 37764122
PMC: 10537529.
DOI: 10.3390/microorganisms11092277.
Tuberculin skin testing and QuantiFERON™-TB Gold Plus positivity among household contacts in Vietnam.
Innes A, Nguyen S, Lebrun V, Nguyen T, Huynh T, Quach V
Public Health Action. 2023; 13(3):83-89.
PMID: 37736581
PMC: 10446657.
DOI: 10.5588/pha.23.0020.
Advances in TB testing.
Pagaduan J, Altawallbeh G
Adv Clin Chem. 2023; 115:33-62.
PMID: 37673521
PMC: 10056534.
DOI: 10.1016/bs.acc.2023.03.003.
Antigen-Induced IL-1RA Production Discriminates Active and Latent Tuberculosis Infection.
Sanchez C, Jaramillo-Valverde L, Capristano S, Solis G, Soto A, Valdivia-Silva J
Microorganisms. 2023; 11(6).
PMID: 37374887
PMC: 10302769.
DOI: 10.3390/microorganisms11061385.
The prevalence of tuberculosis infection in India: A systematic review and meta-analysis.
Chauhan A, Parmar M, Dash G, Solanki H, Chauhan S, Sharma J
Indian J Med Res. 2023; 157(2&3):135-151.
PMID: 37202933
PMC: 10319385.
DOI: 10.4103/ijmr.ijmr_382_23.
Evolution of tuberculosis diagnostics: From molecular strategies to nanodiagnostics.
Mukherjee S, Perveen S, Negi A, Sharma R
Tuberculosis (Edinb). 2023; 140:102340.
PMID: 37031646
PMC: 10072981.
DOI: 10.1016/j.tube.2023.102340.
Progress on diagnosis and treatment of latent tuberculosis infection.
Ying C, He C, Xu K, Li Y, Zhang Y, Wu W
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023; 51(6):691-696.
PMID: 36915977
PMC: 10262000.
DOI: 10.3724/zdxbyxb-2022-0445.
Tuberculosis Infection in Children and Adolescents.
Tchakounte Youngui B, Tchounga B, Graham S, Bonnet M
Pathogens. 2022; 11(12).
PMID: 36558846
PMC: 9784659.
DOI: 10.3390/pathogens11121512.
Safety of a Novel ESAT6-CFP10 skin test compared with tuberculin skin test in a double-blind, randomized, controlled study.
Yang Y, Fang Z, Huang W, Zhang H, Luo S, Lin S
BMC Infect Dis. 2022; 22(1):780.
PMID: 36221062
PMC: 9552410.
DOI: 10.1186/s12879-022-07765-w.
Comprehensive analysis of mycobacterium tuberculosis antigen-specific CD4 T cell responses restricted by single HLA class II allotype in an individual.
Lee Y, Hyun Y, Jo H, Baek I, Kim S, Sohn H
Front Immunol. 2022; 13:897781.
PMID: 35967347
PMC: 9366214.
DOI: 10.3389/fimmu.2022.897781.
Protective Efficacy of BCG Vaccine against and Non-Tuberculous Mycobacterial Infections.
Orujyan D, Narinyan W, Rangarajan S, Rangchaikul P, Prasad C, Saviola B
Vaccines (Basel). 2022; 10(3).
PMID: 35335022
PMC: 8952781.
DOI: 10.3390/vaccines10030390.
Challenges in Developing a Controlled Human Tuberculosis Challenge Model.
Jackson S, McShane H
Curr Top Microbiol Immunol. 2022; 445:229-255.
PMID: 35332386
DOI: 10.1007/82_2022_252.
Strong tuberculin response after BCG vaccination is associated with low multiple sclerosis risk: a population-based cohort study.
Nakken O, Holmoy T, Stigum H, Myhr K, Dahl J, Heldal E
Int J Epidemiol. 2022; 51(5):1637-1644.
PMID: 35278068
PMC: 9557857.
DOI: 10.1093/ije/dyac039.